Aktis Oncology, Inc.
SEC CIK 2035832 · AKTS · last insider filing 2026-04-16
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Gormley Glenn | Director | filed 2026 - 2026 |
| Foley Todd | Director | filed 2026 - 2026 |
| Kim Helen Susan | Director | filed 2026 - 2026 |
| Nodelman Oleg | Director | filed 2026 - 2026 |
| Segal Lloyd Mitchell | Director | filed 2026 - 2026 |
| Ecor1 Capital, LLC | Director | filed 2026 - 2026 |
| Thistle Mary | Director | filed 2026 - 2026 |
| Sherman Michael A. | Director | filed 2026 - 2026 |
| Roden Matthew | Director · President and CEO | filed 2026 - 2026 |
| Herrmann Ken | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kuvalanka Kyle D. | Chief Financial Officer | filed 2026 - 2026 |
| Ron-Bigger Shulamit | Chief Operating Officer | filed 2026 - 2026 |
| Czibere Akos | Chief Medical Officer | filed 2026 - 2026 |
| Feldman Paul L | Chief Scientific Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.